Zenas BioPharma Stock Forecast

Stock Price Forecast

The 7 analysts that cover Zenas BioPharma stock have a consensus rating of "Strong Buy" and an average price target of $37.86, which forecasts a 4.56% increase in the stock price over the next year. The lowest target is $19 and the highest is $46.

Price Target: $37.86 (+4.56%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$19	$37.86	$40	$46
Change	-47.53%	+4.56%	+10.47%	+27.04%

Analyst Ratings

The average analyst rating for Zenas BioPharma stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	4	4	4	4	3	3
Buy	3	3	3	3	3	4
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	6	7

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Judah Frommer Morgan Stanley	Morgan Stanley	Buy Maintains $34 → $37	Buy	Maintains	$34 → $37	+2.18%	Nov 13, 2025
Yigal Nochomovitz Citigroup	Citigroup	Strong Buy Maintains $27 → $46	Strong Buy	Maintains	$27 → $46	+27.04%	Oct 28, 2025
Vikram Purohit Morgan Stanley	Morgan Stanley	Buy Maintains $31 → $34	Buy	Maintains	$31 → $34	-6.10%	Oct 28, 2025
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $30 → $44	Strong Buy	Maintains	$30 → $44	+21.51%	Oct 28, 2025
Martin Fan Wedbush	Wedbush	Buy Maintains $35 → $40	Buy	Maintains	$35 → $40	+10.47%	Oct 9, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

36.55M

from 5.00M

631.00%

from 5.00M

Revenue Next Year

n/a

from 36.55M

EPS This Year

-3.88

from -11.89

EPS Next Year

-4.82

from -3.88

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027	Dec 31, 2028
Revenue	-	50.00M	5.00M	36.55M	-	70.03M	141.70M
Revenue Growth	-	-	-90.00%	631.00%	-	-	102.35%
EPS	-79.94	-24.25	-11.89	-3.88	-4.82	-4.22	-3.89
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	8	8	8	4

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	94.5M	n/a
Avg	36.6M	n/a
Low	9.8M	n/a

Revenue Growth

Revenue Growth	2025	2026
High	1,790.0%	-
Avg	631.0%	-
Low	96.0%	-

EPS Forecast

EPS	2025	2026
High	-2.60	-3.61
Avg	-3.88	-4.82
Low	-4.80	-5.78

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.